The CD8+ T cell immune response to ccRCC was inefficient or diminished, as evidenced by a significant decrease in the proportion of sub‐population CD8+ T cells (FGFBP2) and an increase in CD8+ T cells (NCF1). This evidence concerns the gene FGFBP2 and nonpapillary renal cell carcinoma.